Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size ($ in 1000's) |
---|---|---|---|
Incyte Corporation | 36,179,122 | +556 | $2,271,687 |
INCY | 36,179,122 | +556 | $2,271,687 |
BeiGene Ltd. | 10,568,897 | -1,100,000 | $1,906,206 |
BGNE | 10,568,897 | -1,100,000 | $1,906,206 |
ACADIA Pharmaceuticals Inc. | 42,864,612 | UNCH | $1,342,091 |
ACAD | 42,864,612 | UNCH | $1,342,091 |
Madrigal Pharmaceuticals Inc. | 1,969,798 | +424,685 | $455,772 |
MDGL | 1,969,798 | +424,685 | $455,772 |
Rhythm Pharmaceuticals Inc. | 6,398,365 | -303,984 | $294,133 |
RYTM | 6,398,365 | -303,984 | $294,133 |
Mirati Therapeutics Inc. | 4,121,440 | +2,711,656 | $242,135 |
MRTX | 4,121,440 | +2,711,656 | $242,135 |
Immunocore Holdings plc | 2,520,731 | UNCH | $172,216 |
IMCR | 2,520,731 | UNCH | $172,216 |
Kymera Therapeutics Inc. | 5,995,928 | +1,245,528 | $152,656 |
KYMR | 5,995,928 | +1,245,528 | $152,656 |
Revolution Medicines Inc. | 5,148,657 | +2,457,164 | $147,663 |
RVMD | 5,148,657 | +2,457,164 | $147,663 |
Invitae Corporation | $138,531 | ||
Notes 1 | 300,000,000 | +300,000,000 | $131,152 |
Series A Notes 4 | 9,274,000 | +9,274,000 | $6,273 |
NVTA | 1,764,546 | UNCH | $1,106 |
AbCellera Biologics Inc. | 22,909,753 | +2,146,430 | $130,815 |
ABCL | 22,909,753 | +2,146,430 | $130,815 |
Roivant Sciences Ltd. | 7,593,024 | -4,284,147 | $85,270 |
ROIV | 7,593,024 | -4,284,147 | $85,270 |
Replimune Group Inc. | 9,545,336 | +4,967,056 | $80,467 |
REPL | 9,545,336 | +4,967,056 | $80,467 |
Entrada Therapeutics Inc. | 4,865,819 | UNCH | $73,425 |
TRDA | 4,865,819 | UNCH | $73,425 |
Ultragenyx Pharmaceutical Inc. | 1,466,547 | +100,000 | $70,130 |
RARE | 1,466,547 | +100,000 | $70,130 |
Cerevel Therapeutics Holdings Inc. | 1,600,000 | +1,600,000 | $67,840 |
CERE | 1,600,000 | +1,600,000 | $67,840 |
Immatics N.V. | 5,838,853 | +198,037 | $61,483 |
IMTX | 5,838,853 | +198,037 | $61,483 |
BioCryst Pharmaceuticals Inc. | 10,126,176 | -2,584,642 | $60,656 |
BCRX | 10,126,176 | -2,584,642 | $60,656 |
argenx SE | 151,215 | UNCH | $57,527 |
ARGX | 151,215 | UNCH | $57,527 |
Denali Therapeutics Inc. | 2,607,196 | +315,193 | $55,950 |
DNLI | 2,607,196 | +315,193 | $55,950 |
Akero Therapeutics Inc. | 2,368,378 | UNCH | $55,302 |
AKRO | 2,368,378 | UNCH | $55,302 |
Kodiak Sciences Inc. | 17,310,490 | UNCH | $52,624 |
KOD | 17,310,490 | UNCH | $52,624 |
Kiniksa Pharmaceuticals Ltd. | 2,809,577 | UNCH | $49,280 |
KNSA | 2,809,577 | UNCH | $49,280 |
Xenon Pharmaceuticals Inc. | 993,679 | +242,040 | $45,769 |
XENE | 993,679 | +242,040 | $45,769 |
Prelude Therapeutics Inc. | 10,123,824 | UNCH | $43,229 |
PRLD | 10,123,824 | UNCH | $43,229 |
Cerus Corporation | 19,477,339 | +2,237,838 | $42,071 |
CERS | 19,477,339 | +2,237,838 | $42,071 |
Nurix Therapeutics Inc. | 3,882,125 | UNCH | $40,064 |
NRIX | 3,882,125 | UNCH | $40,064 |
Aerovate Therapeutics Inc. | 1,680,517 | -282,962 | $38,030 |
AVTE | 1,680,517 | -282,962 | $38,030 |
IDEAYA Biosciences Inc. | 1,062,123 | UNCH | $37,790 |
IDYA | 1,062,123 | UNCH | $37,790 |
Edgewise Therapeutics Inc. | 3,112,786 | +2,063,087 | $34,054 |
EWTX | 3,112,786 | +2,063,087 | $34,054 |
Sera Prognostics Inc. | 5,434,399 | +3,919,057 | $32,498 |
SERA | 5,434,399 | +3,919,057 | $32,498 |
Bicycle Therapeutics plc | 1,790,390 | +946,576 | $32,370 |
BCYC | 1,790,390 | +946,576 | $32,370 |
IGM Biosciences Inc. | 3,691,011 | +533,247 | $30,672 |
IGMS | 3,691,011 | +533,247 | $30,672 |
Biomea Fusion Inc. | 2,108,949 | UNCH | $30,622 |
BMEA | 2,108,949 | UNCH | $30,622 |
Monte Rosa Therapeutics Inc. | 4,916,095 | UNCH | $27,776 |
GLUE | 4,916,095 | UNCH | $27,776 |
Verve Therapeutics Inc. | 1,691,530 | +275,000 | $23,580 |
VERV | 1,691,530 | +275,000 | $23,580 |
Krystal Biotech Inc. | 169,934 | UNCH | $21,082 |
KRYS | 169,934 | UNCH | $21,082 |
Gracell Biotechnologies Inc. | 2,080,000 | +1,080,000 | $20,883 |
GRCL | 2,080,000 | +1,080,000 | $20,883 |
Immunovant Inc. | 425,009 | UNCH | $17,906 |
IMVT | 425,009 | UNCH | $17,906 |
TScan Therapeutics Inc. | 2,784,792 | UNCH | $16,235 |
TCRX | 2,784,792 | UNCH | $16,235 |
Day One Biopharmaceuticals Inc. | 1,000,000 | UNCH | $14,600 |
DAWN | 1,000,000 | UNCH | $14,600 |
DBV Technologies S.A. | 14,614,264 | UNCH | $13,924 |
DBVT | 14,614,264 | UNCH | $13,924 |
Relay Therapeutics Inc. | 1,160,117 | UNCH | $12,773 |
RLAY | 1,160,117 | UNCH | $12,773 |
ARS Pharmaceuticals Inc. | 2,006,451 | UNCH | $10,995 |
SPRY | 2,006,451 | UNCH | $10,995 |
Stoke Therapeutics Inc. | 2,030,134 | +544,219 | $10,679 |
STOK | 2,030,134 | +544,219 | $10,679 |
2seventy bio Inc. | 2,497,526 | UNCH | $10,664 |
TSVT | 2,497,526 | UNCH | $10,664 |
Insmed Incorporated | 343,000 | UNCH | $10,630 |
INSM | 343,000 | UNCH | $10,630 |
Celldex Therapeutics Inc. | 247,644 | +247,644 | $9,822 |
CLDX | 247,644 | +247,644 | $9,822 |
Prime Medicine Inc. | 1,028,466 | UNCH | $9,112 |
PRME | 1,028,466 | UNCH | $9,112 |
Neurogene Inc. | 453,516 | +453,516 | $8,789 |
NGNE | 453,516 | +453,516 | $8,789 |
See Full List: All Stocks Held By Baker BROS. Advisors LP
— Including:
Biggest new positions
Biggest exits
Biggest increased positions
Biggest decreased positions
See Details: Top 10 Stocks Held By Baker BROS. Advisors LP
Size ($ in 1000's)
At 12/31/2023: $8,788,584 At 09/30/2023: $17,351,003 Baker BROS. Advisors LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Baker BROS. Advisors LP 13F filings. Link to 13F filings: SEC filings |